A study on the efficacy and safety of risankizumab in the treatment of Crohn’s disease

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: c237097ab4984636f7b6f46b65857de2fa3fa91a
First added on: May 09, 2026